(At Least) Once in Her Lifetime

Global Cervical Cancer Prevention

Philip E. Castle, Amanda Pierz

Research output: Contribution to journalReview article

Abstract

Cervical cancer disproportionately burdens lower-resourced settings, in which nearly 90% of cervical cancer and cervical cancer–related deaths occur. Targeting human papillomavirus (HPV) by prophylactic HPV vaccination in young adolescent girls and HPV-based screening in mid-adult women offers the most cost-effective strategy to reduce cervical cancer burden worldwide and mitigate the health disparities in cervical cancer burden between low-resourced and high-resourced settings. Political and social will, along with the necessary financial investments, will be necessary to realize the opportunity for significant global reductions in the cervical cancer burden. Perfect cervical cancer prevention (total eradication) is practically and financially unrealistic.

Original languageEnglish (US)
Pages (from-to)107-123
Number of pages17
JournalObstetrics and Gynecology Clinics of North America
Volume46
Issue number1
DOIs
StatePublished - Mar 1 2019

Fingerprint

Uterine Cervical Neoplasms
Vaccination
Costs and Cost Analysis

Keywords

  • Cervical cancer
  • Cervical intraepithelial neoplasia (CIN)
  • Cytology
  • Global health
  • Human papillomavirus (HPV)
  • Pap
  • Screening
  • Vaccination

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

(At Least) Once in Her Lifetime : Global Cervical Cancer Prevention. / Castle, Philip E.; Pierz, Amanda.

In: Obstetrics and Gynecology Clinics of North America, Vol. 46, No. 1, 01.03.2019, p. 107-123.

Research output: Contribution to journalReview article

@article{81f25db21be7441f9c523b2d1830a97b,
title = "(At Least) Once in Her Lifetime: Global Cervical Cancer Prevention",
abstract = "Cervical cancer disproportionately burdens lower-resourced settings, in which nearly 90{\%} of cervical cancer and cervical cancer–related deaths occur. Targeting human papillomavirus (HPV) by prophylactic HPV vaccination in young adolescent girls and HPV-based screening in mid-adult women offers the most cost-effective strategy to reduce cervical cancer burden worldwide and mitigate the health disparities in cervical cancer burden between low-resourced and high-resourced settings. Political and social will, along with the necessary financial investments, will be necessary to realize the opportunity for significant global reductions in the cervical cancer burden. Perfect cervical cancer prevention (total eradication) is practically and financially unrealistic.",
keywords = "Cervical cancer, Cervical intraepithelial neoplasia (CIN), Cytology, Global health, Human papillomavirus (HPV), Pap, Screening, Vaccination",
author = "Castle, {Philip E.} and Amanda Pierz",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.ogc.2018.09.007",
language = "English (US)",
volume = "46",
pages = "107--123",
journal = "Obstetrics and Gynecology Clinics of North America",
issn = "0889-8545",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - (At Least) Once in Her Lifetime

T2 - Global Cervical Cancer Prevention

AU - Castle, Philip E.

AU - Pierz, Amanda

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Cervical cancer disproportionately burdens lower-resourced settings, in which nearly 90% of cervical cancer and cervical cancer–related deaths occur. Targeting human papillomavirus (HPV) by prophylactic HPV vaccination in young adolescent girls and HPV-based screening in mid-adult women offers the most cost-effective strategy to reduce cervical cancer burden worldwide and mitigate the health disparities in cervical cancer burden between low-resourced and high-resourced settings. Political and social will, along with the necessary financial investments, will be necessary to realize the opportunity for significant global reductions in the cervical cancer burden. Perfect cervical cancer prevention (total eradication) is practically and financially unrealistic.

AB - Cervical cancer disproportionately burdens lower-resourced settings, in which nearly 90% of cervical cancer and cervical cancer–related deaths occur. Targeting human papillomavirus (HPV) by prophylactic HPV vaccination in young adolescent girls and HPV-based screening in mid-adult women offers the most cost-effective strategy to reduce cervical cancer burden worldwide and mitigate the health disparities in cervical cancer burden between low-resourced and high-resourced settings. Political and social will, along with the necessary financial investments, will be necessary to realize the opportunity for significant global reductions in the cervical cancer burden. Perfect cervical cancer prevention (total eradication) is practically and financially unrealistic.

KW - Cervical cancer

KW - Cervical intraepithelial neoplasia (CIN)

KW - Cytology

KW - Global health

KW - Human papillomavirus (HPV)

KW - Pap

KW - Screening

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85060293381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060293381&partnerID=8YFLogxK

U2 - 10.1016/j.ogc.2018.09.007

DO - 10.1016/j.ogc.2018.09.007

M3 - Review article

VL - 46

SP - 107

EP - 123

JO - Obstetrics and Gynecology Clinics of North America

JF - Obstetrics and Gynecology Clinics of North America

SN - 0889-8545

IS - 1

ER -